Peer Review reports
From: Guideline for the management of pediatric off-label use of drugs in China (2021)
| Original Submission | ||
|---|---|---|
| 6 Mar 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 7 May 2022 | Reviewed | Reviewer Report |
| 7 May 2022 | Reviewed | Reviewer Report |
| 23 May 2022 | Reviewed | Reviewer Report |
| 31 May 2022 | Author responded | Author comments - Yaolong Chen |
| Resubmission - Version 3 | ||
| 31 May 2022 | Submitted | Manuscript version 3 |
| 2 Jun 2022 | Author responded | Author comments - Yaolong Chen |
| Resubmission - Version 4 | ||
| 2 Jun 2022 | Submitted | Manuscript version 4 |
| 3 Jun 2022 | Author responded | Author comments - Yaolong Chen |
| Resubmission - Version 5 | ||
| 3 Jun 2022 | Submitted | Manuscript version 5 |
| 10 Jun 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 27 Jun 2022 | Editorially accepted | |
| 23 Jul 2022 | Article published | 10.1186/s12887-022-03457-1 |
You can find further information about peer review here.